Newron Points ‘Future Value-Driver’ Evenamide At Drug-Resistant Schizophrenia

Following Phase II Promise

 
• By Ayisha Sharma
  
One head split into two faces, one red and one blue, representing concept of schizophrenia
Schizophrenia Affects Around 24 Million People Worldwide • Source: Shutterstock

More from Clinical Trials

More from R&D